Розмір відео: 1280 X 720853 X 480640 X 360
Показувати елементи керування програвачем
Автоматичне відтворення
Автоповтор
Biotecnología y acciones 🤔 curiosa combinación
Links & referencesir.tonixpharma.com/news-events/press-releases/detail/1541/tonix-pharmaceuticals-announces-fda-acceptance-of-the-newir.tonixpharma.com/sec-filings/quarterly-reports/content/0001999371-24-014569/0001999371-24-014569.pdfir.tonixpharma.com/sec-filings/all-sec-filings/content/0001839882-24-046554/0001839882-24-046554.pdfYT restricts the links, for more: ir.tonixpharma.com/news-events/press-releases/ir.portagebiotech.com/node/10196/pdfir.portagebiotech.com/node/10221/pdfwww.globenewswire.com/news-release/2022/07/20/2482751/0/en/Portage-Biotech-Acquires-Outstanding-Minority-Interest-of-Invariant-Natural-Killer-T-cell-iNKT-Agonist-Platform.htmlwww.biopathholdings.com/wp-content/uploads/2024/12/BP1001-A_Obesity_Initial_Efficacy_Testing.pdfwww.mtem.com/news-media/press-releases/detail/143/molecular-templates-announces-notice-of-delisting-and
Biotecnología y acciones 🤔 curiosa combinación
Links & references
ir.tonixpharma.com/news-events/press-releases/detail/1541/tonix-pharmaceuticals-announces-fda-acceptance-of-the-new
ir.tonixpharma.com/sec-filings/quarterly-reports/content/0001999371-24-014569/0001999371-24-014569.pdf
ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001839882-24-046554/0001839882-24-046554.pdf
YT restricts the links, for more: ir.tonixpharma.com/news-events/press-releases/
ir.portagebiotech.com/node/10196/pdf
ir.portagebiotech.com/node/10221/pdf
www.globenewswire.com/news-release/2022/07/20/2482751/0/en/Portage-Biotech-Acquires-Outstanding-Minority-Interest-of-Invariant-Natural-Killer-T-cell-iNKT-Agonist-Platform.html
www.biopathholdings.com/wp-content/uploads/2024/12/BP1001-A_Obesity_Initial_Efficacy_Testing.pdf
www.mtem.com/news-media/press-releases/detail/143/molecular-templates-announces-notice-of-delisting-and